This project has received funding from the European Union’s 7th Framework Programme for research, technological development and demonstration under grant agreement no 611709
Subcribe to our mailing list
> Delivering value to European SMEs and entrepeneurs
Follow this project on F6S
Follow us on twitter
Loading Twitter messages...
Are you interested in eHealth opportunities
in the USA market? View are our recorded webinar here
27. July 2015
The GET project is pleased to announce that we have secured Dave Whitlinger, Executive Director New York eHealth Collaborative to be the guest speaker on an international Webinar to look at:
‘eHealth business opportunities and things to consider when entering the USA market’
Dave’s current position has overall responsibility for the New York eHealth Collaborative, a non-profit organization promoting health information technology that ensures fast, secure, accurate
access to patient data across New York State.
This webinar is targeted to ambitious eHealth entrepreneurs who are interested in moving into the USA market and was held on July 7, at 2 PM CET.
Please find the recording of the webinar here: webinar
(apologies for the bad recordings)
Dave Whitlinger, Execute Director, New York eHealth Collaborative
As Executive Director, Dave has overall responsibility for the New York eHealth Collaborative, a non-profit organization promoting health information technology that ensures fast, secure,
accurate access to patient data across New York State. Previously, Dave served as the Director of Healthcare Device Standards and Interoperability for the Intel Corporation in its Digital
Health Group, responsible for healthcare device interoperability strategies and standards development. He led a cross-industry consortium, the Continua Health Alliance, focused on the
establishment of an ecosystem of interoperable, personal telehealth systems. He also served on the Bluetooth SIG Board of Directors for several years. Dave is the author of five
research journal articles, four of which focused on breast cancer DNA analysis.